Parkinson's disease trials recruiting in Illinois

All Parkinson's disease trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
  NCT06565195 · Phase: Phase 1 · Ages: 30 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago
• A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's
  NCT04664634 · Phase: Phase 3 · Ages: 22 Years and older · Sex: All (male and female) · Illinois: Evanston
• A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
  NCT06680830 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago
• A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
  NCT04991831 · Phase: Not specified · Ages: 30 Years to 99 Years · Sex: All (male and female) · Illinois: Chicago
• A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
  NCT06285643 · Phase: Phase 2 · Ages: 45 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago
• A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
  NCT06765668 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Winfield
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
  NCT06976268 · Phase: Phase 2, Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago
• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
  NCT07174310 · Phase: Phase 3 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Illinois: Chicago
• A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
  NCT06944522 · Phase: Phase 3 · Ages: 45 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago
• A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
  NCT07330258 · Phase: Not specified · Ages: 45 Years to 75 Years · Sex: All (male and female) · Illinois: Winfield
• Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
  NCT06719583 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• GBPDC: Gut-Brain in PD Consortium Master Protocol
  NCT07567794 · Phase: Not specified · Ages: 21 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago
• Non-invasive VNS for Parkinson's Gait
  NCT06562569 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 88 Years · Sex: All (male and female) · Illinois: Hines
• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
  NCT04477785 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Illinois: Chicago
• Parkinson's Foundation PD GENEration Genetic Registry
  NCT04994015 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago, Evanston
• Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
  NCT04373317 · Phase: Phase 4 · Ages: 40 Years and older · Sex: All (male and female) · Illinois: Hines
• Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
  NCT02071134 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Use of CereGate Therapy for Freezing of Gait in PD
  NCT05292794 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago
• rTMS to Improve Cognition in Parkinson's
  NCT03836950 · Phase: Phase 1, Phase 2 · Ages: 50 Years and older · Sex: All (male and female) · Illinois: Chicago, Hines